Key result
Cardioneuroablation achieves partial vagal denervation in a patient with cardioinhibitory carotid sinus syndrome.
Why the study?
Does cardioneuroablation prevent syncope recurrence in patients with cardioinhibitory carotid sinus syndrome?
Case Report (n=1)
Does cardioneuroablation prevent syncope recurrence in patients with cardioinhibitory carotid sinus syndrome?
Partial vagal denervation over the sinus node during cardioneuroablation may be insufficient to prevent syncope recurrence in patients with cardioinhibitory carotid sinus syndrome.
May be insufficient to prevent syncope recurrence; hypothesis-generating and leaves open cardioneuroablation efficacy in cardioinhibitory carotid sinus syndrome.
Cardioneuroablation (CNA) has been proposed as an alternative treatment for patients with refractory vasovagal syncope (VVS), functional atrioventricular block (AVB), or functional bradyarrhythmia instead of classical treatment or pacemaker.1 Vagal denervation is achieved by endocardial catheter ablation targeting atrial fibrillation nests (AFN)2 and ganglionic plexus (GP)-related areas. We describe a clinical case of cardioinhibitory carotid sinus syndrome (CSS) treated with CNA, where partial vagal denervation was achieved over sinus node.
No takes yet. Share an insight, caveat, or question.
Acosta et al. (2022) conducted a case report in Cardioinhibitory carotid sinus syndrome (n=1). Cardioneuroablation was evaluated on Vagal denervation. Cardioneuroablation achieved partial vagal denervation over the sinus node in a patient with cardioinhibitory carotid sinus syndrome.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: